APA

Jatoi A., Steen P. D., Atherton P. J., Moore D. F., Rowland K. M., Le-Lindqwister N. A., Adonizio C. S., Jaslowski A. J., Sloan J. & Loprinzi C. (20180507). A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Jatoi A, Steen P D, Atherton P J, Moore D F, Rowland K M, Le-Lindqwister N A, Adonizio C S, Jaslowski A J, Sloan J and Loprinzi C. 20180507. A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Jatoi A., Steen P. D., Atherton P. J., Moore D. F., Rowland K. M., Le-Lindqwister N. A., Adonizio C. S., Jaslowski A. J., Sloan J. and Loprinzi C. (20180507). A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Jatoi A, Steen P D, Atherton P J, Moore D F, Rowland K M, Le-Lindqwister N A, Adonizio C S, Jaslowski A J, Sloan J and Loprinzi C. A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. : Annals of oncology : official journal of the European Society for Medical Oncology. 20180507.